An agreement has been reached between BioNTech and Bristol Myers Squibb for the worldwide co-development and co-commercialization of BioNTech's investigational bispecific antibody BNT327 across a variety of solid tumor types.
The Authentication Solution Providers’ Association (ASPA) ahead of World Anti-Counterfeiting Day, has commissioned the second edition of its flagship industry report, ‘State of Counterfeiting in India – 2025
Aumolertinib (Aumseqa) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for adult patients with non-small cell lung cancer (NSCLC).
Gland Pharma Limited saw its shares rise nearly 3% during intraday trading on Wednesday following the announcement of a major regulatory accomplishment...
India is about to give a significant boost to its production-linked incentive (PLI) scheme for pharmaceuticals as it seeks to establish a stronger domestic production of key starting materials (KSMs)...
According to Chairman and Managing Director Dilip Shanghvi, Sun Pharmaceutical Industries has secured a USD 100 million investment to commercialize innovative pharmaceuticals in the current fiscal year
The Directorate General of Trade Remedies (DGTR) has rescheduled the oral hearing for its ongoing anti-dumping investigation into imports of mono ethylene glycol (MEG) from Kuwait, Saudi Arabia, and Singapore...
India has officially surpassed Japan to become the fourth-largest economy in the world, with a GDP of over USD 4 trillion, as per NITI Aayog CEO BVR Subrahmanyam. According to Rajiv Nath, Forum...
Divi's Laboratories Limited has entered into a long-term manufacturing and supply agreement with a leading global pharmaceuticals company to manufacture and supply advanced intermediates that...
Lupin pharmaceutical announced that it has entered into a license and supply agreement with SteinCares for the commercialization of biosimilar ranibizumab throughout all of Latin America...
.jpg)
.jpg)
, CDSCO.jpg)